1. Home
  2. FTCI vs CALC Comparison

FTCI vs CALC Comparison

Compare FTCI & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$11.87

Market Cap

93.0M

Sector

Technology

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.01

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
CALC
Founded
2017
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
88.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FTCI
CALC
Price
$11.87
$6.01
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.50
$16.00
AVG Volume (30 Days)
87.4K
104.8K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$80,028,000.00
N/A
Revenue This Year
$113.41
N/A
Revenue Next Year
$106.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.53
N/A
52 Week Low
$2.13
$1.42
52 Week High
$12.70
$7.20

Technical Indicators

Market Signals
Indicator
FTCI
CALC
Relative Strength Index (RSI) 58.47 57.37
Support Level $11.52 $5.55
Resistance Level $12.70 $7.20
Average True Range (ATR) 0.84 0.80
MACD 0.03 -0.11
Stochastic Oscillator 68.21 50.48

Price Performance

Historical Comparison
FTCI
CALC

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: